HomeCompareMDT vs ACN

MDT vs ACN: Dividend Comparison 2026

MDT yields 3.31% · ACN yields 3.30%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ACN wins by $45.28M in total portfolio value
10 years
MDT
MDT
● Live price
3.31%
Share price
$85.74
Annual div
$2.84
5Y div CAGR
29.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$54.3K
Annual income
$9,789.15
Full MDT calculator →
ACN
ACN
● Live price
3.30%
Share price
$197.55
Annual div
$6.52
5Y div CAGR
85.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$45.34M
Annual income
$40,254,140.02
Full ACN calculator →

Portfolio growth — MDT vs ACN

📍 ACN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMDTACN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MDT + ACN cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MDT pays
ACN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MDT
Annual income on $10K today (after 15% tax)
$281.55/yr
After 10yr DRIP, annual income (after tax)
$8,320.78/yr
ACN
Annual income on $10K today (after 15% tax)
$280.54/yr
After 10yr DRIP, annual income (after tax)
$34,216,019.02/yr
At 15% tax rate, ACN beats the other by $34,207,698.24/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MDT + ACN for your $10,000?

MDT: 50%ACN: 50%
100% ACN50/50100% MDT
Portfolio after 10yr
$22.70M
Annual income
$20,131,964.59/yr
Blended yield
88.71%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ACN right now

MDT
Analyst Ratings
1
Strong
26
Buy
22
Hold
Consensus: Buy
Price Target
$111.45
+30.0% upside vs current
Range: $100.00 — $120.00
Altman Z
2.9
Piotroski
7/9
ACN
Analyst Ratings
39
Buy
13
Hold
1
Sell
Consensus: Buy
Price Target
$299.92
+51.8% upside vs current
Range: $265.00 — $330.00
Altman Z
4.3
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MDT buys
0
ACN buys
0
No recent congressional trades found for MDT or ACN in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMDTACN
Forward yield3.31%3.30%
Annual dividend / share$2.84$6.52
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR29.3%85.1%
Portfolio after 10y$54.3K$45.34M
Annual income after 10y$9,789.15$40,254,140.02
Total dividends collected$29.9K$44.91M
Payment frequencyquarterlyquarterly
SectorHealthcareTechnology
Analyst consensusBuyBuy
Analyst price target$111.45$299.92

Year-by-year: MDT vs ACN ($10,000, DRIP)

YearMDT PortfolioMDT Income/yrACN PortfolioACN Income/yrGap
1← crossover$11,128$428.29$11,311$610.91$183.00ACN
2$12,483$575.94$13,298$1,195.36$815.00ACN
3$14,138$780.71$16,660$2,431.14$2.5KACN
4$16,196$1,068.46$23,095$5,268.91$6.9KACN
5$18,809$1,479.09$37,347$12,635.37$18.5KACN
6$22,201$2,075.70$75,308$35,346.62$53.1KACN
7$26,716$2,960.69$203,877$123,297.57$177.2KACN
8$32,891$4,305.30$795,585$577,436.45$762.7KACN
9$41,599$6,405.16$4,749,302$3,898,026.13$4.71MACN
10$54,300$9,789.15$45,335,893$40,254,140.02$45.28MACN

MDT vs ACN: Complete Analysis 2026

MDTHealthcare

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Full MDT Calculator →

ACNTechnology

Accenture plc, a professional services company, provides strategy and consulting, interactive, and technology and operations services worldwide. The company offers application services, including agile transformation, DevOps, application modernization, enterprise architecture, software and quality engineering, data management, intelligent automation comprises robotic process automation, natural language processing, and virtual agents, and liquid application management services, as well as program, project, and service management services; strategy consulting services; critical data elements, data management and governance, data platform and architecture, product-based organization and skills, business adoption, and value realization services; engineering, and research and development digitization; smart connected product design and development; product platform engineering and modernization; product as-a-service enablement; products related to production and operations; autonomous robotics systems; the digital transformation of capital projects; and digital industrial workforce solutions. It also provides data-enabled operating models; technology consulting and artificial intelligence services; services related to talent and organization/human potential; digital commerce; infrastructure services, such as hybrid cloud, network, digital workplace and collaboration, service and experience management, infrastructure as code, and managed edge and IoT devices; cyber defense, applied cybersecurity, managed security, OT security, security strategy and risk, and industry security products; services related to technology innovation; and intelligent automation services. In addition, the company offers cloud, ecosystem, marketing, supply chain management, zero-based budgeting, customer experience, finance consulting, mergers and acquisitions, and sustainability services. Accenture plc was founded in 1951 and is based in Dublin, Ireland.

Full ACN Calculator →
📬

Get this MDT vs ACN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MDT vs SCHDMDT vs JEPIMDT vs OMDT vs KOMDT vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.